Search clinical trials for: ADP receptor inhibitors
Total 76791 results
-
Royal Marsden NHS Foundation TrustRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomAstraZeneca; Cancer Research UKRecruitingGynaecological CancersUnited Kingdom
-
University of UtahClovis Oncology, Inc.Terminated
-
Mario Negri Institute for Pharmacological ResearchNorth Eastern German Society of Gynaecological OncologyActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaItaly, Germany
-
Dana-Farber Cancer InstituteTesaro, Inc.Active, not recruiting
-
Matthew GalskyIcahn School of Medicine at Mount Sinai; AstraZenecaCompletedMetastatic Urothelial CancerUnited States
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
PfizerTerminated
-
UNICANCERClovis Oncology, Inc.; Fondation ARCCompletedMetastatic Breast CancerFrance
-
AstraZenecaNo longer availablePSR Ovarian Cancer With a BRCA MutationJapan
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownNon Small Cell Lung CancerFrance
-
Dana-Farber Cancer InstituteWithdrawnOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
GlaxoSmithKlineRecruiting
-
OnxeoRecruitingBreast Cancer | Metastatic Castration-resistant Prostate Cancer | Recurrent Epithelial Ovarian CancerUnited States
-
Yongpeng WangRecruiting
-
Centre Leon BerardGlaxoSmithKlineRecruitingMetastatic Pancreatic CancerFrance
-
Haider MahdiPfizer; Zenith EpigeneticsRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
University of ChicagoAstraZenecaRecruitingMesothelioma | Homologous Recombination DeficiencyUnited States
-
Northwell HealthTesaro, Inc.RecruitingEndometrial Cancer | Endometrial Carcinoma | Uterine Serous Carcinoma | Cancer of the Endometrium | Papillary Serous Endometrial CarcinomaUnited States
-
Massachusetts General HospitalPfizerRecruiting
-
Shadia Jalal, MDGlaxoSmithKline; Indiana University School of MedicineTerminatedAdenocarcinoma | Gastric Cancer | Esophageal CancerUnited States
-
University of ArizonaActive, not recruiting
-
AstraZenecaActive, not recruitingSolid TumorsBelgium, United Kingdom, Switzerland, Australia
-
North Eastern German Society of Gynaecological...Clovis Oncology, Inc.; Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus...Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Clear Cell CarcinomaGermany
-
PfizerCompletedBreast Neoplasms | Metastatic Breast CancerUnited States
-
PfizerActive, not recruitingNeoplasms | Breast NeoplasmsJapan
-
Ospedale Policlinico San MartinoCRO "Centro Clinical Trials" IRCCS Ospedale Policlinico San Martino; Laboratory...Withdrawn
-
GlaxoSmithKlineActive, not recruitingNeoplasms, BreastUnited States, Argentina, France, Netherlands, Finland, Spain, Israel, Poland, Romania, Mexico, Canada, Belgium, Germany, Hungary, Portugal, United Kingdom, Ireland, Australia, Italy, Brazil, Japan, Austria, Russian Federation, South... and more
-
AstraZenecaBritish Columbia Cancer AgencyCompleted
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...CompletedRenal Cell CarcinomaChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityZai Lab (Shanghai) Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedPlatinum-resistant Recurrent Clear Cell Ovarian CancerChina
-
Spanish Oncology Genito-Urinary GroupAstraZeneca; Apices Soluciones S.L.CompletedProstate Cancer MetastaticSpain
-
AstraZenecaCompletedBreast Cancer | Ovarian CancerIndia
-
Samsung Medical CenterCompleted
-
MedSIRAstraZeneca; ExperiorCompleted
-
Yale UniversityWithdrawnSquamous Cell Carcinoma of the Head and Neck
-
AbbVieCompletedOncology | High Grade Serous Ovarian Cancer | BRCA Mutated | BRCA Mutated Breast Cancer
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProgressive Disease | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Carcinoma | Endometrial Adenocarcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Platinum-Resistant Ovarian Carcinoma | High Grade Ovarian... and other conditionsUnited States
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer MetastaticChina
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMalignant Solid TumorsUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruitingAdvanced Breast CancerUnited Kingdom
-
University of WashingtonAstraZenecaTerminatedCastration-Resistant Prostate Carcinoma | Prostate AdenocarcinomaUnited States
-
University of Alabama at BirminghamTerminatedOvarian Cancer | Resistant BRCA Wild-Type Ovarian CancerUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2
-
AdaptimmuneRecruitingMyxoid Liposarcoma | Synovial SarcomaUnited States, United Kingdom, Canada, France, Spain
-
University of MiamiGlaxoSmithKlineNot yet recruiting
-
Sunnybrook Health Sciences CentreGlaxoSmithKlineRecruitingOvarian Cancer | Stage IV Ovarian Cancer | High Grade Ovarian Serous Adenocarcinoma | Stage III Ovarian CancerCanada
-
Zhejiang Cancer HospitalSun Yat-sen University; Fujian Cancer Hospital; Hunan Cancer Hospital; Zhejiang... and other collaboratorsNot yet recruitingTriple Negative Breast Cancer | Homologous Recombination Deficiency
-
SOLTI Breast Cancer Research GroupRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-negative Breast CancerSpain
-
Ling-Ying WuNot yet recruiting